SCHEMBL18240282

SCHEMBL18240282

COc1cc(OC)c(C(=O)C(=CN(C)C)C(=O)O)cc1I

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
PAX8 Q06710 1/20 0.40
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 1/20 0.38
ACHE P22303 2/20 0.36
BACE1 P56817 2/20 0.36
APP P05067 1/20 0.33
ALDH1A1 P00352 5/20 0.32
MAPT P10636 3/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 2/20 0.31
KMT2A Q03164 1/20 0.31
GAA P10253 1/20 0.31
TUBB1 Q9H4B7 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18240280 1.00 CYP3A4 (0.41) CYP3A4PAX8CYP11B1CYP11B2ACHE
SCHEMBL16461662 0.88 CYP3A4 (0.40) CYP3A4PAX8CYP11B1CYP11B2ACHE
SCHEMBL16461661 0.88 CYP3A4 (0.40) CYP3A4PAX8CYP11B1CYP11B2ACHE
SCHEMBL16462011 0.84 KMT2A (0.41) CYP3A4PAX8CYP11B1CYP11B2ACHE
SCHEMBL16462013 0.84 KMT2A (0.41) CYP3A4PAX8CYP11B1CYP11B2ACHE
SCHEMBL2181651 0.83 CYP11B1 (0.41) CYP3A4PAX8CYP11B1CYP11B2ALDH1A1
SCHEMBL2181660 0.83 CYP11B1 (0.41) CYP3A4PAX8CYP11B1CYP11B2ALDH1A1
SCHEMBL16462241 0.82 CYP3A4 (0.35) CYP3A4PAX8ACHEBACE1APP
SCHEMBL16462243 0.82 CYP3A4 (0.35) CYP3A4PAX8ACHEBACE1APP
SCHEMBL29702273 0.74 CYP11B1 (0.35) CYP11B1CYP11B2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906529-B9 A NEW PRODUCTION METHOD AND NEW INTERMEDIATES OF SYNTHESIS OF ELVITEGRAVIR ZENTIVA KS (CZ) 2017-03-15 EP disclosed
EP-2906529-B1 A NEW PRODUCTION METHOD AND NEW INTERMEDIATES OF SYNTHESIS OF ELVITEGRAVIR ZENTIVA KS (CZ) 2016-11-23 EP disclosed